Commerce and Industry Minister Piyush Goyal has strongly refuted claims that Indian pharmaceutical companies engage in ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Patent lawyers are racing to adapt how they draft and defend drug-device patents after a court ruling reshaped the FDA’s ...

Goyal positioned India's approach as protecting the rights of both innovators and consumers, arguing that companies should be able to recover their research and development investments during the ...